Sorrento Therapeutics, Inc. (SRNE)

Sorrento Therapeutics Revenue

Sorrento Therapeutics had revenue of $15.03M in the quarter ending June 30, 2023, with 31.10% growth. This brings the company's total for the last twelve months to $64.27M, up 16.89% year-over-year. In the year 2022, Sorrento Therapeutics had annual revenue of $62.84M with 18.78% growth. That makes Sorrento Therapeutics the 26,054th largest company in the world by revenue and 3,587th in the United States.

• Revenue (ttm): 64.27M
• Revenue Growth: +16.89%
• P/S Ratio: 0.01
• Revenue / Employee: 67.72K
• Employees: 949
• Market Cap: 434.97K

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Scilex 38.03M 60.5%
• Sorrento Therapeutics 24.81M 39.5%

Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	62.84M	9.94M	18.78%
Dec 31, 2021	52.90M	12.92M	32.31%
Dec 31, 2020	39.99M	8.55M	27.21%
Dec 31, 2019	31.43M	10.24M	48.31%
Dec 31, 2018	21.19M	-130.66M	-86.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error